Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522626 · ClinicalTrials.gov registry record
Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 19
- Enrollment target
NCT00522626: Completed study, sponsored by Johns Hopkins University.
NCT00522626 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00522626 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This study seeks to elucidate fetal neurobehavioral development in fetuses of opioid dependent women who have either undergone and completed methadone detoxification,or who never received methadone maintenance, and are not methadone maintained at 36 weeks gestation. This research will determine how fetal neurobehavioral functioning in fetuses of opioid dependent, non-methadone maintained women differs from that of fetuses whose opioid dependent mothers are methadone maintained. The project will utilize a state-of-the-art computerized fetal actocardiograph and data analysis program to simultaneously evaluate fetal movement and heart rate, the interaction between the two and maternal physiologic parameters.
Interventions
- DEVICE Maternal fetal monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2006-08 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00522626
The ClinicalTrials.gov registry entry for NCT00522626 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Maternal fetal monitoring is the first listed.
NCT00522626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00522626 about?
NCT00522626 is a clinical study titled "Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment". This study seeks to elucidate fetal neurobehavioral development in fetuses of opioid dependent women who have either undergone and completed methadone detoxification,or who never received methadone maintenance, and are not methadone maintained at 36 weeks gestation. This research will determine how ...
What is the current status of trial NCT00522626?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2006-08. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00522626?
The interventions under investigation include: Maternal fetal monitoring (DEVICE).
Who is sponsoring clinical trial NCT00522626?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.